Risk Factors Associated with Trastuzumab-induced Cardiotoxicity in Patients with Human Epidermal Growth Factor Receptor 2-positive Breast Cancer.

J Pharm Bioallied Sci · 2019 · PMC6791087 · PMID 31619917

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

nearly significantP = 0.0700so close (0.05 < p ≤ 0.1)

However, tumor site and previous treatment with taxane were nearly significant (OR = 3.68; 95% CI: 0.90–15.03; P = 0.0700 and OR = 1.72; 95% CI: 0.93–3.21; P = 0.0863, respectively).

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.